Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis

BACKGROUND/AIMS: Studies have shown that nucleos(t)ide analogue (NA) treatment can reduce the risk of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients, but it is unclear which NA is most effective. We performed a meta-analysis and systematic review comparing the efficacies of NAs...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinhui, Liu, Xiaoli, Dang, Zhibo, Yu, Lihua, Jiang, Yuyong, Wang, Xianbo, Yang, Zhiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096226/
https://www.ncbi.nlm.nih.gov/pubmed/31158948
http://dx.doi.org/10.5009/gnl18546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096226/
https://www.ncbi.nlm.nih.gov/pubmed/31158948
http://dx.doi.org/10.5009/gnl18546

Ejemplares similares